Apollo enters Punjab with Apollo Cradle & Apollo Clinic in Amritsar

IMT News Desk
IMT News Desk
· 3 min read

Apollo Hospitals marked its’ first investment into the state of Punjab, with the launch of Apollo Cradle and Apollo Clinic in Amritsar. Apollo Cradle, a hospital for women and children, is one of India’s leading players’ to offer a premium maternity experience. Cradle, with 12 centres across India, was born out of the belief that maternity is not an illness but a time for celebration. Apollo Clinic is a multi-specialty clinic where there are specialists Drs, diagnostics, treatment facilities, including dental and physiotherapy, all under one roof. With the launch of the 79th clinic in India, and the 1st in Amritsar, residents of Amritsar will now have access to the expertise of Apollo and its’ Apollo Health Checks in their neighbourhood.

Apollo Cradle and Apollo Clinic, located on Court Road in Amritsar, provide world-class infrastructure, the best in Apollo’s clinical processes and protocols and its’ trademark ‘tender loving care’ to the residents of the city. Apollo Cradle has international standard operating theatres, a level III neonatal ICU that can handle the most complex pre-term babies, a pediatric ICU and ward and luxurious patient rooms. The hospital also boasts of high-end diagnostic equipment including a 4D ultrasound machine that can detect fetal anomalies. The Apollo Clinic has multiple departments, with patients getting a choice of the best Drs and diagnostics under one roof.

Speaking on Apollo’s entry into Punjab, and specifically Amritsar, Ms Sangita Reddy, Joint Managing Director, Apollo Hospitals Enterprise Limited said, “Apollo has always had a strong commitment to the people in India, and we have been creating a network of healthcare concepts that ensure comprehensive care across the continuum of care. With the launch of Apollo Cradle and Apollo Clinic in Amritsar, we will be able to serve the residents of Amritsar and neighbouring districts. The world class Level III neonatal ICU will make a huge difference in bridging the gap in treatment options currently for pre-term babies born in this region. Also, our maternity services combine the best of clinical excellence that Apollo has to offer with an unparalled luxury experience that every expecting mother deserves. A Cradle combines the clinical excellence of Apollo Hospital, the warmth of a home and the luxury of a hotel. In Amritsar, this is literally the case, with the Cradle being established in a building which was part of a 5 star hotel earlier.”

Commenting on this launch, Mr Neeraj Garg, CEO, Apollo Health and Lifestyle said, “There is a virtual epidemic of non-communicable diseases in India. The economic cost of diabetes, cardiovascular disease, respirator disorder and cancer, is going to be huge. Individuals have to take the responsibility for managing their health better. Apollo Clinics are playing a significant role in helping alleviate the burden of NCDs in India. Early detection is critical to the management of NCDs, and with the Apollo Health Checks program, residents of Amritsar must pledge to get their health checked each year so that they win the battle against NCDs. The Apollo Clinic will also make daily healthcare simpler and more convenient, with all Drs, diagnostics and treatment facilities all under one roof.”

Apollo Cradle provides services for women that include maternity and pre-natal programs, gynecology procedures, fertility treatment, fetal medicine and for children that include pediatric medical care, neonatal ICU. The Apollo Clinic has specialist doctors in general medicine, cardiology, diabetes, orthopedics, ENT, dermatology, along with a dental treatment room, physiotherapy, stress-test, echo and ultrasound tests, X-ray, ECG and lung function testing.

Read Next

Sun Pharma receives DCGI approval to manufacture, market generic semaglutide injection in India for chronic weight management
Corporate
January 27, 2026

Sun Pharma receives DCGI approval to manufacture, market generic semaglutide injection in India for chronic weight management

Company to launch product after the expiry of semaglutide patent in India Sun Pharmaceutical Industries has received approval from the Drugs Controller General of India (DCGI) to manufacture and market a generic version of semaglutide injection. Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is indicated for chronic weight management in adults as an adjunct to […]
Article by: IMT News Desk
Lupin receives highest ESG rating from CDP for climate change and water security
Corporate
January 27, 2026

Lupin receives highest ESG rating from CDP for climate change and water security

The recognition affirms Lupin’s position among distinguished global leaders who champion sustainability and transparency at the highest level Lupin has received the highest ‘A’ leadership rating from Climate Disclosure Project (CDP) for its exceptional accomplishments in Climate Change and Water Security. The recognition affirms Lupin’s position among distinguished global leaders who champion sustainability and transparency […]
Article by: IMT News Desk
AstraZeneca Pharma India receives CDSCO approval for breast cancer drug
Corporate
December 19, 2025

AstraZeneca Pharma India receives CDSCO approval for breast cancer drug

Dato-DXd is a specifically engineered antibody drug conjugate that targets TROP2, a protein frequently overexpressed in breast cancer AstraZeneca Pharma India announced that the Central Drugs Standard Control Organisation (CDSCO) has granted regulatory approval to import, sell, and distribute Datopotamab Deruxtecan (Dato-DXd) in India. The approval reflects AstraZeneca’s focus on bringing to life-changing medicines at […]
Article by: IMT News Desk
Novo Nordisk launches Ozempic in India
Corporate
December 12, 2025

Novo Nordisk launches Ozempic in India

Ozempic is a once-weekly GLP-1 RA (receptor agonist) indicated as an adjunct to diet and exercise for adults living with uncontrolled type 2 diabetes mellitus Novo Nordisk announced the launch of Ozempic (injectable semaglutide) in India. Ozempic is a once-weekly GLP-1 RA (receptor agonist) indicated as an adjunct to diet and exercise for adults living […]
Article by: IMT News Desk